Research & Development

18 Jun 2020
- Drug Discovery
- Research & Development
Interdisciplinary consortium receives grant to develop next-generation cell-based cancer vaccines

By PBR Staff Writer

Cell-based cancer vaccines are revolutionizing the treatment of previously incurable cancers. Access to these promising therapies is limited by the high costs of manufacturing at centralized locations. Saint-Gobain Life Sciences, Kanyr Pharma Inc., the RI-MUHC and McGill University have formed a new interdisciplinary consortium to make this technology more accessible. In this project, dendritic cell cancer vaccines will be generated in Saint-Gobain’s VueLife® “C” Series FEP bags.
17 Jun 2020
Drug Discovery
Research & Development
IDEAYA and GSK announce a broad partnership in Synthetic Lethality

By PBR Staff Writer

IDEAYA Biosciences, Inc. (Nasdaq: IDYA) and GlaxoSmithKline plc (GSK) announce a strategic partnership in Synthetic Lethality, an emerging field in Oncology.
17 Jun 2020
Drug Discovery
Research & Development
Takeda, Neurocrine sign $2bn deal on potential therapies for psychiatric disorders

By PBR Staff Writer

Takeda Pharmaceutical has entered into a more than $2bn worth deal with Neurocrine Biosciences to develop potential therapies for psychiatric disorders.
15 Jun 2020
Drug Discovery
Research & Development
Clinical Trials
Cannabinoid Purification and Scale-Up on Hipersep^® Pilot

By victoria.smith

For the outstanding efficiency and scalability, high-performance liquid chromatography (HPLC) has been widely used for purification of high-quality APIs and intermediates in the pharmaceutical industry.
12 Jun 2020
Drug Discovery
Research & Development
Clinical Trials
PureO₃ Dissolved Ozone Sensor

By victoria.smith

The new pureO₃ Dissolved Ozone Sensor with Intelligent Sensor Management (ISM^®) technology provides robust, reliable measurement with increased stability in pure water applications.
10 Jun 2020
Research & Development
Drug Discovery
Autobahn Therapeutics launches with $76m Series B financing to develop next generation therapies for CNS disorders

By PBR Staff Writer

Financing co-led by ARCH Venture Partners and Cowen Healthcare Investments
09 Jun 2020
Drug Discovery
Research & Development
MMS to support IGY Life Sciences in advancing Covid-19 antibody candidate

By PBR Staff Writer

IGY Life Sciences has entered into a collaboration with MMS Holdings, a data-focused clinical research organisation (CRO), to advance the development of its anti-CoV-2 therapeutic antibody IgY-110.
08 Jun 2020
Drug Discovery
Research & Development
AbbVie, HBM, UU, and EMC to develop Covid-19 antibody therapeutic

By PBR Staff Writer

AbbVie has joined forces with Harbour BioMed (HBM), Utrecht University (UU), and Erasmus Medical Center (EMC) to develop a novel antibody therapeutic for the prevention and treatment of Covid-19.
05 Jun 2020
Drug Discovery
Research & Development
Cullinan Oncology completes $98.5m Series B financing

By PBR Staff Writer

Cullinan Oncology, LLC announced today the closing of a $98.5 million Series B financing, which will be used to support ongoing clinical trials across its small molecule and biologics portfolio.
05 Jun 2020
Drug Discovery
Research & Development
Memo Therapeutics identifies potent SARS-CoV-2-neutralising antibodies from blood of recovered Covid-19 patients

By PBR Staff Writer

Memo Therapeutics, an innovator in the field of antibody discovery and immune repertoire analysis, today announces that it has identified several SARS-CoV-2-specific virus-neutralizing antibodies with the potential for development as a Covid-19 immunotherapy.

Drug Discovery

Research & Development

SciNeuro and Novartis sign global licensing deal for Alzheimer’s antibody

Atara receives FDA complete response letter for Ebvallo BLA application

Clinical Trials

Patient Enrollment

US FDA approves Avacta Group’s IND application for AVA6000

AM-Pharma enrols first patients in Covid-19 phase III trial

Regulation

Drug Filing

Viatris files applications in Japan for approval of Effexor to treat GAD

Scholar Rock submits application of SMA therapy to FDA

Production & Sales

Manufacturing

ENCell and Lucy Biotech forge alliance for mesenchymal stem cell therapy

Merck introduces single-use reactor to accelerate ADC manufacturing

Packaging & Supply Chain

Packaging

Gerresheimer at CPHI Frankfurt 2025

Gerresheimer

Suppliers

No data found

Research & Development

Interdisciplinary consortium receives grant to develop next-generation cell-based cancer vaccines

IDEAYA and GSK announce a broad partnership in Synthetic Lethality

Takeda, Neurocrine sign $2bn deal on potential therapies for psychiatric disorders

Cannabinoid Purification and Scale-Up on Hipersep^® Pilot

PureO₃ Dissolved Ozone Sensor

Autobahn Therapeutics launches with $76m Series B financing to develop next generation therapies for CNS disorders

MMS to support IGY Life Sciences in advancing Covid-19 antibody candidate

AbbVie, HBM, UU, and EMC to develop Covid-19 antibody therapeutic

Cullinan Oncology completes $98.5m Series B financing

Memo Therapeutics identifies potent SARS-CoV-2-neutralising antibodies from blood of recovered Covid-19 patients

Pharmaceutical Business review is using cookies

Research & Development

Patient Enrollment

Drug Filing

Manufacturing

Packaging

No data found